Expanded collaboration with Thermo Fisher Scientific combines the new Seer Proteograph™ XT Assay Kit with the new Thermo Scientific™ Orbitrap™ Astral™ Mass Spectrometer to empower the scientific community to dig deeper into the proteome REDWOOD CITY, Calif. — Seer, Inc. (NASDAQ: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today […]
STOCKHOLM — MGI Tech Co. Ltd. (“MGI”), a company committed to building core tools and technology to lead life science, are delighted to announce a comprehensive collaboration with AddLife AB, one of Europe’s largest distributors of clinical testing and laboratory equipment, headquartered in Stockholm. This partnership aims to significantly enhance the distribution of MGI products* in the Nordic region, […]
FOSTER CITY, Calif. — Acrobat Genomics, NanoString Technologies, Inc. (NASDAQ:NSTG), and the Illumina Accelerator announced today their collaboration with Stanford Medicine to discover new drug targets for gene editing-based therapeutics using GeoMx® Digital Spatial Profiling (DSP) technology. This collaboration aims to improve treatment options for patients suffering from interstitial lung diseases, such as idiopathic pulmonary […]
BOSTON — The Institute for Protein Innovation (IPI), a nonprofit research institute, and Addgene, a global nonprofit biorepository, today announced a strategic partnership to accelerate biomedical research and therapeutic development through the discovery, development, and distribution of recombinant antibodies and other protein and DNA reagents. This partnership will help address the ongoing need by the global […]
LAUSANNE, Switzerland and DANVERS, MA, USA – Lunaphore, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, and Cell Signaling Technology (CST), a life science discovery technology company and leading provider of antibodies, kits, and services, today announced a partnership to enable the use of CST® antibodies on the Lunaphore COMET™ platform, a scalable […]
DKSH has signed a new partnership with Quantabio, a leading provider of DNA and RNA reagents for molecular testing applications in life science research, in Thailand. Bangkok, Thailand – DKSH Business Unit Technology has signed an agreement with Quantabio, LLC. DKSH will provide full Market Expansion Services, including market insights, marketing and sales, distribution and […]
Together, an extensive panel of consented patient samples and iPSC technology will advance AD drug development and patient stratification. CAMBRIDGE / EDINBURGH and ALDERLEY PARK, UK: Axol Bioscience Ltd. (Axol), a leading pluripotent stem cell technology provider for drug discovery has signed an exclusive agreement with StrataStem to access and commercialize its extensive collection of Alzheimer’s […]
Signing of an agreement by Dr. Kimberly Cline, President of Long Island University and Mr. Antoine Turzi, President of RegenLab USA LLC, for the creation of an industrial innovation accelerator dedicated to cell therapies and tissue engineering integrated into the “Dassault Systèmes Center of Excellence” Establishment of a teaching program with Long Island University, with […]
On May 19, Shimadzu Corporation has invested in ChromaCode Inc. (ChromaCode), a startup with technology to expand genetic testing, through its corporate venture capital (CVC) fund, Shimadzu Future Innovation Fund L.P. (Shimadzu FIF). This is Shimadzu FIF’s first investment. ChromaCode is a startup that expands the number of target genes available in existing PCR with […]
News Summary: Integration of Sartorius’ process scale multi-column chromatography with Waters’ process analytical technology to provide robust analytical data for downstream biomanufacturing of mAbs, recombinant proteins, vaccines, and other biologics. Integrated solution to deliver vital analytical data in days, not weeks – and to reduce waste and help lower drug production costs. Bioprocess scientists will […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
